RBC Capital Upgrades Medtronic to Outperform, Raises Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
RBC Capital has upgraded Medtronic to 'Outperform' and increased its price target from $98 to $105, indicating a positive outlook for the company's stock.
October 10, 2024 | 2:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has upgraded Medtronic from 'Sector Perform' to 'Outperform' and increased the price target from $98 to $105, suggesting a positive short-term outlook for the stock.
The upgrade from 'Sector Perform' to 'Outperform' by RBC Capital, along with an increased price target, typically signals confidence in the company's future performance, likely leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100